MGC018

· MacroGenics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MGC018, covering 2025-07-31 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer [Phase 2]